Tamoxifen citrate

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Application

Tamoxifen citrate

Tamoxifen citrate

Synonym(s): cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate Formula: C26H29NO.C6H8O7 Formula weight: 563.

A potent synthetic anti-estrogen. A cell-permeable and reversible inhibitor of protein kinase C (IC 50 = 10 &#181M).

Synonym(s): cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate Formula: C26H29NO.C6H8O7 Formula weight: 563.

Grade: USP CAS No.: 54965-24-1

Grade: USP CAS No.: 54965-24-1

Tamoxifen-ethyl-d5 is a labeled, nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. Tamoxifen is a protein kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines.

General description Toremifene is a triphenylethylene derivative. It exhibits antitumor and antiestrogen effects.

General description Toremifene is a triphenylethylene derivative. It exhibits antitumor and antiestrogen effects.